Glycogen synthase kinase 3 (GSK-3) is a serine/threonine protein kinase that has recently emerged as a promising target in drug discovery. It is involved in multiple cellular processes and associated with the pathogenesis of several diseases. A three-dimensional quantitative structure-activity relationship (3D-QSAR) analysis was performed on a series of GSK-3 inhibitors to understand the structural basis for inhibitory activity. Comparative molecular field analysis (CoMFA) method was used to derive 3D-QSAR models. A reliable CoMFA model was developed using ligand-based alignment scheme. The model produced statistically acceptable results with a cross-validated correlation coefficient (q 2 ) of 0.594 and a non-cross-validated correlation coefficient (r 2 ) of 0.943. Robustness of the model was checked by bootstrapping and progressive scrambling analysis. This study could assist in the design of novel compounds with enhanced GSK-3 inhibitory activity.
Introduction
Glycogen synthase kinase-3 (GSK-3) is a multifunctional serine/threonine protein kinase. It is ubiquitously expressed protein kinase that exists in two isoforms, α and β [1, 2] . It is involved in diverse physiological pathways ranging from metabolism, cell cycle, gene expression, development and oncogenesis to neuroprotection. It has been implicated in several diseases such as diabetes, inflammation, cancer, Alzheimer's and bipolar disorder [3] [4] [5] [6] . High-level expression of GSK-3 in brain is associated with a variety of neurological disorders like Alzheimer's, bipolar disorder, Huntington disease and other neurodegenerative disorders [7, 8] . Due to the therapeutic potential, development of GSK-3 inhibitors is a focus of research for pharmaceutical companies and academic researchers [9] . In recent years, various efforts have been made to discover GSK-3 inhibitors. The availability of GSK-3 crystal structures allows structure-based lead discovery and optimization [10, 11] . Consequently, several GSK-3 inhibitors have been reported till date. Recently, a novel class of 5-aryl-4-carboxamide-1,3-oxazoles has been reported as potent inhibitors of GSK-3 [12] . However, a quantitative structure-activity relationship (QSAR) study on these inhibitors has not been carried out to establish exactly how their chemical structures relate to the inhibitory activities. Our research group has reported several molecular modeling studies [13] [14] [15] [16] [17] [18] . In this study, we have performed comparative molecular field analysis (CoMFA) to identify the key structural elements that are required in the rational design of potential drug candidates of this class.
Methodology

Data Set
A data set of 31 GSK-3 inhibitors was collected from the literature [12] . Biological activities of the inhibitors were reported as pIC 50 values. These values span 4 log units, suggesting a suitable data set for a QSAR study. The reported pIC 50 values were used as the dependent variables in the CoMFA model. The X-ray crystal structure 4AFJ with resolution of 1.98 Å [12] was obtained from the Protein Data Bank (PDB, http://www.rcsb.org/ pdb). The extracted co-crystallized ligand (compound 7) was used as template to construct the 3D structures of all the compounds. The chemical structures and activities of the inhibitors are given in Table 1 . Structures of the compounds were sketched using Sybylx2.0 [19] . GasteigerHückel partial atomic charges were applied. The common moiety was constraint for each compound and only the varying parts were energy minimized using Tripos force field. The minimized structures were aligned to the template compound using common substructurebased alignment method.
CoMFA
CoMFA is based on the hypothesis that changes in the biological activity are related to the changes in the steric and electrostatic fields of compounds [20] . CoMFA descriptors (steric and electrostatic field energies) were calculated using default settings. A 3D cubic lattice with a grid spacing of 2.0 Å was created and fields were generated using a sp 3 carbon probe atom carrying +1 charge and van der Waals radius of 1.50 Å. Steric and electrostatic fields were calculated from Lennard-Jones and Coulomb potentials, respectively. An energy cut-off of 30 kcal mol -1 was used.
Partial least squares (PLS) regression algorithm was used to derive relationship between the structural parameters and the biological activities [21] . In PLS analysis, pIC 50 values were used as dependent variables and CoMFA descriptors were used as independent variables. The leave-one-out (LOO) cross-validation was performed to obtain cross-validated correlation coefficient (q 2 ), optimal number of components (NOC) and standard error of prediction (SEP). In LOO cross-validation, one compound was removed from the data set and its activity was predicted using the model derived from the remaining compounds. The non-cross-validated analysis was carried out to determine non-cross-validated correlation coefficient (r 2 ), standard error of estimate (SEE) and F-test value (F). Developed model was further validated using bootstrapping analysis and progressive scrambling. Bootstrapping of 100 runs and a total of 100 independent scramblings with a minimum of 2 bins and a maximum of 10 bins were carried out.
Results and Discussion
CoMFA Model
CoMFA models were developed using a series of GSK-3 inhibitors. Ligand-based alignment scheme was used for generation of CoMFA models from the whole data set. All compounds were aligned over the template using common substructure alignment method. The aligned compounds are shown in Fig. 1 Table 2 . PLS analysis showed a high q 2 value of 0.594 with 4 components. The non-cross-validated analysis produced r 2 , Fig. 1 . Alignment of data set compounds based on common substructure using compound 7 as a template. Table 3 . The scatter plot for actual versus predicted pIC 50 values is presented in Fig. 2 . Activities predicted by the model are in agreement with the experimental values suggesting that a reliable CoMFA model was developed.
CoMFA Contour Maps
The CoMFA results were graphically interpreted by the field contribution maps using the STDEV*COEFF field type. The contour maps of different field contribution of the model are presented with template (compound 7). Maps describe default 80% and 20% level contributions for favorable and unfavorable regions, respectively. Maps show spatial requirement of steric and electrostatic fields for improving the inhibitory activity.
Steric contour map is shown in Fig. 3 . Green contours represent favorable regions for bulky group substitution while yellow contours represent unfavorable regions for One more yellow contour near pyridine ring of the R 1 substitution indicates that small groups in the region could be favorable to enhance the activity. Thus, compound 4 with smaller R 1 substituent than compound 3 display higher activity. Electrostatic contour map is shown in Fig. 4 . Blue contours indicate regions where electropositive substitutions enhance the activity whereas red contours indicate regions where electronegative substitutions increase the potency. A big blue contour observed near methoxy group of R 2 substitution suggests that electropositive substitution in that position could increase the activity of compounds. This could be the reason why compounds 7 exhibit higher activity than compounds 9 and 10. The small red contour seen near the pyridine ring of the R 1 position suggests that the substitution that have electronegative group in that particular position could improve the activity. This could be the reason why compound 24 containing chlorine atom in that position exhibit higher activity than compound 25.
Conclusions
In this study, 3D-QSAR models were developed for a series of GSK-3 inhibitors. CoMFA provided some insights into the key structural factors affecting the bioactivity of these inhibitors. A reliable ligand-based CoMFA model was obtained with Gasteiger-Hückel partial charges. The model exhibited statistically significant results in terms of q 2 and r 2 values. Model was validated using bootstrapping and progressive sampling. Validation results indicated that the model is predictable and robust. Analysis of contour maps provided information to understand the SAR and highlighted regions to improve the activity of the compounds. Smaller groups with electronegative properties at R 1 substitution whereas electropositive groups at R 2 substitution are desirable to improve the inhibitory potency. These results may provide some useful and rational suggestions for further design of novel GSK-3 inhibitors. 
